These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 23062233)

  • 1. S-1 in colorectal cancer: a new standard of care?
    Grothey A
    Lancet Oncol; 2012 Nov; 13(11):1068-70. PubMed ID: 23062233
    [No Abstract]   [Full Text] [Related]  

  • 2. Oral fluoropyrimidine treatment of colorectal cancer.
    Eng C; Kindler HL; Schilsky RL
    Clin Colorectal Cancer; 2001 Aug; 1(2):95-103. PubMed ID: 12445367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Development of oral drugs in the standard therapy for metastatic colorectal cancer patients].
    Kato K
    Nihon Rinsho; 2011 Apr; 69 Suppl 3():454-8. PubMed ID: 22214003
    [No Abstract]   [Full Text] [Related]  

  • 4. [Present status of chemotherapy for colorectal cancer in countries outside of Japan].
    Doi T; Ohtsu A
    Nihon Rinsho; 2003 Sep; 61 Suppl 7():368-73. PubMed ID: 14574915
    [No Abstract]   [Full Text] [Related]  

  • 5. S-1 plus oxaliplatin versus capecitabine plus oxaliplatin for first-line treatment of patients with metastatic colorectal cancer: a randomised, non-inferiority phase 3 trial.
    Hong YS; Park YS; Lim HY; Lee J; Kim TW; Kim KP; Kim SY; Baek JY; Kim JH; Lee KW; Chung IJ; Cho SH; Lee KH; Shin SJ; Kang HJ; Shin DB; Jo SJ; Lee JW
    Lancet Oncol; 2012 Nov; 13(11):1125-32. PubMed ID: 23062232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. S-1 plus oxaliplatin versus capecitabine plus oxaliplatin for the first-line treatment of patients with metastatic colorectal cancer: updated results from a phase 3 trial.
    Kim ST; Hong YS; Lim HY; Lee J; Kim TW; Kim KP; Kim SY; Baek JY; Kim JH; Lee KW; Chung IJ; Cho SH; Lee KH; Shin SJ; Kang HJ; Shin DB; Lee JW; Jo SJ; Park YS
    BMC Cancer; 2014 Nov; 14():883. PubMed ID: 25424120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Feasibility study of oxaliplatin with oral S-1 or capecitabine as first-line therapy for patients with metastases from colorectal cancer.
    Watanabe K; Kawahara H; Enomoto H; Toyama Y; Akiba T; Yanaga K
    Anticancer Res; 2013 Sep; 33(9):4029-32. PubMed ID: 24023346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The choice of treatment in advanced gastric cancer].
    Pozzo C; Mansueto G
    Tumori; 2007; 93(6):suppl 11-21. PubMed ID: 18338512
    [No Abstract]   [Full Text] [Related]  

  • 9. Capecitabine combinations in the treatment of advanced colorectal cancer.
    Fisher MD
    Clin Colorectal Cancer; 2001 Nov; 1(3):146-8. PubMed ID: 12450426
    [No Abstract]   [Full Text] [Related]  

  • 10. Should capecitabine replace infusional fluorouracil and leucovorin when combined with oxaliplatin in metastatic colorectal cancer?
    Mayer RJ
    J Clin Oncol; 2007 Sep; 25(27):4165-7. PubMed ID: 17709796
    [No Abstract]   [Full Text] [Related]  

  • 11. Capecitabine plus oxaliplatin in metastatic colorectal cancer.
    Cassidy J
    J Clin Oncol; 2007 Nov; 25(31):5043-5; author reply 5045-6. PubMed ID: 17971611
    [No Abstract]   [Full Text] [Related]  

  • 12. The clinical and economic benefits of capecitabine and tegafur with uracil in metastatic colorectal cancer.
    Almond J; Ralston S
    Br J Cancer; 2007 May; 96(9):1489; author reply 1490. PubMed ID: 17437019
    [No Abstract]   [Full Text] [Related]  

  • 13. Comments on final report of the AIO Colorectal Cancer Group Study: fluorouracil/oxaliplatin versus capecitabine/oxaliplatin.
    Buechele T
    J Clin Oncol; 2007 Nov; 25(31):5041-2; author reply 5042-3. PubMed ID: 17971610
    [No Abstract]   [Full Text] [Related]  

  • 14. Usefulness of monthly chemotherapy for patients with unresectable metastatic colorectal cancer.
    Tomoda M; Kawahara H; Watanabe K; Enomoto H; Akiba T; Yanaga K
    Anticancer Res; 2014 Jan; 34(1):191-4. PubMed ID: 24403461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. S-1 for advanced colorectal cancer: do we need another oral fluorouracil prodrug?
    Schmoll HJ
    Lancet Oncol; 2010 Sep; 11(9):808-9. PubMed ID: 20816370
    [No Abstract]   [Full Text] [Related]  

  • 16. [Intravenous continuous infusion of fluorouracil for treatment of metastatic colorectal cancer].
    Hosokawa A
    Nihon Rinsho; 2003 Sep; 61 Suppl 7():352-5. PubMed ID: 14574911
    [No Abstract]   [Full Text] [Related]  

  • 17. [Progress in chemotherapy for colorectal cancer].
    Sasaki T; Maeda Y
    Gan To Kagaku Ryoho; 2000 Dec; 27(14):2185-92. PubMed ID: 11142161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single agent fluorouracil for first-line treatment of advanced colorectal cancer as standard?
    Schmoll HJ; Sargent D
    Lancet; 2007 Jul; 370(9582):105-107. PubMed ID: 17630019
    [No Abstract]   [Full Text] [Related]  

  • 19. Efficacy of combination chemotherapy using oral fluoropyrimidine S-1 with oxaliplatin (SOX) against colorectal cancer in vivo.
    Nukatsuka M; Saito H; Sakamoto K; Nakagawa F; Uchida J; Kobunai T; Shiraishi K; Takechi T
    Anticancer Res; 2012 Jul; 32(7):2807-12. PubMed ID: 22753741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New advances in the treatment of gastric cancer.
    Ilson DH
    J Natl Compr Canc Netw; 2004 Sep; 2 Suppl 3():S-29-33. PubMed ID: 23570096
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.